Digestive Diseases and Sciences

, Volume 42, Issue 6, pp 1199–1209 | Cite as

Immunohistochemical Studies on EGF Family Growth Factors in Normal and Ulcerated Human Gastric Mucosa

  • Shinya Abe
  • Hironobu Sasano
  • Katsuaki Katoh
  • Shuichi Ohara
  • Tadashi Arikawa
  • Tetsuya Noguchi
  • Shigeru Asaki
  • Wataru Yasui
  • Eiichi Tahara
  • Hiroshi Nagura
  • Takayoshi Toyota
Article

Abstract

Expression of members of the epidermal growthfactor family, including epidermal growth factor (EGF),transforming growth factor-α (TGF-α),amphiregulin (AR), and Cripto, as well as their putative receptor, epidermal growth factor receptor(EGFR), was studied immunohistochemically in humangastric mucosa to evaluate their possible roles in cellproliferation of normal and regenerative gastric mucosa. We also examined the correlation between cellproliferation and EGFR by double immunohistochemicalstaining for proliferating cell nuclear antigen (PCNA)and EGFR. In normal gastric mucosa, TGF-α, Cripto, and AR immunoreactivities were observed in thesurface epithelial and parietal cells of gastric fundicglands, respectively. EGF immunoreactivity was notobserved in any of normal mucosa examined. EGFR immunoreactivity was detected on foveolar cellsin proliferative zones and in parietal cells. Doubleimmunostaining revealed that EGFR immunoreactivity wasdistributed much more widely than PCNA immunoreactivity. PCNA positive epithelial cells adjacent togastric ulcer margin expressed relatively intense EGFRbut did not express any of the growth factors examined.On the other hand, relatively intense immunoreactivity of both TGF-α and Cripto was detected inPCNA-negative regenerative epithelium located distantfrom gastric ulcer margin. Relative immunoreactivity ofAR in regenerative gastric epithelium associated with ulcer was not different from that innormal gastric mucosa. TGF-α, AR, and Cripto areconsidered to play important roles in normal gastricmucosal proliferation, and TGF-α and Cripto may be involved in ulcer healing, possibly via aparacrine mechanism.

EPIDERMAL GROWTH FACTOR TRANSFORMING GROWTH FACTOR-α AMPHIREGULIN EPIDERMAL GROWTH FACTOR RECEPTOR CRIPTO GASTRIC ULCER 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

REFERENCES

  1. 1.
    Marquardt H, Hunkapiller MM, Hood LE, Todaro GJ: Rat transforming growth factor type 1: structure and relation to epidermal growth factor. Science 223:1079–1082, 1984Google Scholar
  2. 2.
    Larco JE, Todaro GJ: Growth factors from murine sarcoma virus-transformed cells. Proc Natl Acad Sci USA 75:4001–4005, 1978Google Scholar
  3. 3.
    Beauchamp RD, Barnard JA, McCutchen CM, Cherner JA, Coffey RJ: Localization of transforming growth factor alpha and its receptor in gastric mucosal cells. Implications for a regulatory role in acid secretion and mucosal renewal. J Clin Invest 84:1017–1023, 1989Google Scholar
  4. 4.
    Shoyab M, McDonald VL, Bradley JG, Todaro GJ: Amphi-regulin: A bifunctional growth-modulating glycoprotein produced by the phorbol 12-myristate 13-acetate-treated human breast adenocarcinoma cell line MCF-7. Proc Natl Acad Sci USA 85:6528–6532, 1988Google Scholar
  5. 5.
    Shoyab M, Plowman GD, McDonald VL, Bradley JG, Todaro GJ: Structure and function of human amphiregulin: A member of the epidermal growth factor family. Science 243:1074–1076, 1989Google Scholar
  6. 6.
    Kitadai Y, Yasui W, Yokozaki H, Kuniyasu H, Ayhan A, Haruma K, Kajiyama G, Johnson GR, Tahara E: Expression of amphiregulin, a novel gene of the epidermal growth factor family, in human gastric carcinomas. Jpn J Cancer Res 84:879–884, 1993Google Scholar
  7. 7.
    Ciccodicola A, Dono R, Obici S, Simeone A, Zollo M, Persico MG: Molecular characterization of a gene of the ‘EGF family’ expressed in undifferentiated human NTERA2 teratocarcinoma cells. EMBO J 8:1987–1991, 1989Google Scholar
  8. 8.
    Kuniyasu H, Yoshida K, Yokozaki H, Yasui W, Ito H, Toge T, Ciardiello F, Persico MG, Saeki T, Salomon DS, et al: Expression of Cripto, a novel gene of the epidermal growth factor family, in human gastrointestinal carcinomas. Jpn J Cancer Res 82:969–973, 1991Google Scholar
  9. 9.
    Cohen S: Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in the newborn animal. J Biol Chem 237:1155–1162, 1962Google Scholar
  10. 10.
    Gregory S: Isolation and structure of urogastrone and its relationship to epidermal growth factor. Nature 257:325–327, 1975Google Scholar
  11. 11.
    Konturek JW, Brozozowski T, Konturek SJ: Epidermal growth factor in protection, repair, and healing of gastroduodenal mucosa. J Clin Gastroentreol 13:88–97, 1991Google Scholar
  12. 12.
    Konturek JW, Bielanski W, Konturek SJ, Bogdal J, Oleksy J: Distribution and release of epidermal growth factor in man. Gut 30:1194–1200, 1989Google Scholar
  13. 13.
    Mori M, Naito R, Tsukitani K, Okada Y, Tsujimura T: Widespread distribution of human epidermal growth factor (hEGF) in human tissues and organs under normal and tumorous conditions-immunohistochemical studies with the use of polyclonal and monoclonal antibodies. Acta Histochem 22:15–34, 1989Google Scholar
  14. 14.
    Savage CR, Inagami T, Cohen S: The primary structure of epidermal growth factor. J Biol Chem 247:7612–7621, 1972Google Scholar
  15. 15.
    Jonson LR, Paul D: Stimulation of rat oxyntic gland mucosal growth by epidermal growth factor. Am J Physiol 238:G45–G49, 1980Google Scholar
  16. 16.
    Skinner KA, Soper BD, Tepperman BL: Effect of sialoadenectomy and salivery gland extracts on gastrointestinal mucosal growth and gastrin levels in the rat. J Physiol 351:1–12, 1984Google Scholar
  17. 17.
    Konturek SJ, Brzozowski T, Majka J, Dembinski A, Slomiany A, Slomiany BL: Transforming growth factor alpha and epidermal growth factor in protection and healing of gastric mucosal injury. Scand J Gastroenterol 27:649–655, 1992Google Scholar
  18. 18.
    Konturek SJ, Bielanski W, Konturek JW, Oleksy J, Yamazaki J: Release and action of epidermal growth factor on gastric secretion in humans. Scand J Gastroenterol 24:485–492, 1989Google Scholar
  19. 19.
    Brzozowski T, Majka J, Garlicki J, Drozdowicz D, Konturek SJ: Role of polyamines and prostaglandins in gastroprotective action of epidermal growth factor against ethanol injury. J Clin Gastroenterol 13:S98–S102, 1991Google Scholar
  20. 20.
    Okita K, Karita M, Nakanishi N, Takemoto T: Role of epidermal growth factor in protection and repair of gastric mucosal injury. J Clin Gastroenterol 13:S103–S108, 1991Google Scholar
  21. 21.
    Sarosiek J, Bilski J, Murty VLN, Slomiany A, Slomiany BL: Role of salivary epidermal growth factor in the maintenance of physicochemical characteristics of oral and gastric mucosal mucus coat. Biochem Biophys Res Commun 152:1421–1427, 1988Google Scholar
  22. 22.
    Imai S, Itoh M, Katsumi K, Yokoyama Y, Miyamoto T, Joh T, Ikeda K, Matsusako K, Noguchi Y, Tomomatsu T, Yasue N, Takeuchi T: Effects of endogenous epidermal growth factor (EGF) on acid secretion, intramucosal mucus and HCl-induced mucosal injury in the stomach in submandibular gland removed rats. Nippon Shokakibyo Gakkai Zasshi 84:1573–1578, 1987Google Scholar
  23. 23.
    Carpenter G, Cohen S: Epidermal growth factor. J Biol Chem 265:7709–7712, 1990Google Scholar
  24. 24.
    Sottili M, Sternini C, Brecha NC, Lezoche E, Walsh JH: Transforming growth factor alpha receptor binding sites in the canine gastrointestinal tract. Gastroenterology 103:1427–1436, 1992Google Scholar
  25. 25.
    Tarnawski A, Stachura J, Durbin T, Gergely H: Expression of epidermal growth factor receptor in rat gastric oxyntic mucosa. J Clin Gastroenterol 13:109–113, 1991Google Scholar
  26. 26.
    Tarnawski A, Lu S-Y, Stachura J, Sarfeh IJ: Adaptation of gastric mucosa to chronic alcohol administration is associated with increased mucosal expression of growth factors and their receptor. Gastroenterology 27:59–63, 1992Google Scholar
  27. 27.
    Johnson GR, Saeki T, Gordon AW, Shoyab M, Salomon DS, Stromberg K: Autocrine action of amphiregulin in a colon carcinoma cell line and immunocytochemical localization of amphiregulin in human colon. J Cell Biol 118:741–751, 1992Google Scholar
  28. 28.
    Sasano H, Date F, Imatani A, Asaki S, Nagura H: Double immunostaining for c-erbB-2 and p53 in human stomach cancer cells. Hum Pathol 24:584–589, 1993Google Scholar
  29. 29.
    Thomas DM, Nasim MM, Gullick WJ, Alison MR: Immunoreactivity of transforming growth factor alpha in the normal adult gastrointestinal tract. Gut 33:628–631, 1992Google Scholar
  30. 30.
    Nasim MM, Thomas DM, Alison MR, Filipe MI: Transforming growth factor alpha expression in normal gastric mucosa, intestinal metaplasia, dysplasia and gastric carcinoma—an immunohistochemical study. Histopathology 20:339–343, 1992Google Scholar
  31. 31.
    Saeki T, Stromberg K, Qi C-F, Gullick WJ, Tahara E, Normanno N, Ciardiello F, Kenny N, Johnson GR, Salomon DS: Differential immunohistochemical detection of amphiregulin and Cripto in human normal colon and colorectal tumors. Cancer Res 52:3467–3473, 1992Google Scholar
  32. 32.
    Polk WH, Dempsey PJ, Russell WE, Brown PI, Beauchamp RD, Barnard JA, Coffey RJ: Increased production of transforming growth factor a following acute gastric injury. Gastroenterology 102:1467–1474, 1992Google Scholar
  33. 33.
    Tahara E: Molecular mechanism of stomach carcinogenesis. J Cancer Res Clin Oncol 119:265–272, 1993Google Scholar
  34. 34.
    Mori S, Morishita Y, Saeki K, Kurimoto S, Okamoto M, Kawamoto T, Kuroki T: Electron microscopic evidence for epidermal growth factor receptor (EGF-R)-like immunoreactivity associated with the basolateral surface of gastric parietal cells. Acta Pathol Jpn 37:1909–1917, 1987Google Scholar
  35. 35.
    Scheving LA, Shiurba RA, Nguyen TD, Gray GM: Epidermal growth factor of the intestinal enterocyte localization to laterobasal but not brush border membrane. J Biol Chem 264:1735–1741, 1989Google Scholar
  36. 36.
    Konturek SJ, Dembinski A, Warzecha Z, Brzozowski T, Gregory H: Role of epidermal growth factor in healing of chronic gastroduodenal ulcers in rats. Gastroenterology 94:1300–1307, 1988Google Scholar
  37. 37.
    Chen MC, Lee AT, Karnes WE, Avedian D, Martin M, Sorvillo JM, Soll AH: Paracrine control of gastric epithelial cell growth in culture by transforming growth factor-α. Am J Physiol 264:390–396, 1993Google Scholar
  38. 38.
    Wright NA, Pike C, Elia G: Induction of a novel epidermal growth factor-secreting cell lineage by mucosal ulceration in human gastrointestinal stem cells. Nature 343:82–85, 1990Google Scholar
  39. 39.
    Lee H, Hansson HA, Norstrom E, Helander HF: Immunoreactivities for epidermal growth factor (EGF) and for EGF receptors in rats with gastric ulcers. Cell Tissue Res 265:211–218, 1991Google Scholar
  40. 40.
    Folkman J, Szabo S, Stovoroff M, et al: Duodenal ulcer: Discovery of a new mechanism and development of angiogenic therapy that accelerates healing. Ann Surg 214:414–427, 1991Google Scholar

Copyright information

© Plenum Publishing Corporation 1997

Authors and Affiliations

  • Shinya Abe
  • Hironobu Sasano
  • Katsuaki Katoh
  • Shuichi Ohara
  • Tadashi Arikawa
  • Tetsuya Noguchi
  • Shigeru Asaki
  • Wataru Yasui
  • Eiichi Tahara
  • Hiroshi Nagura
  • Takayoshi Toyota

There are no affiliations available

Personalised recommendations